Kaplan–Meier analysis showed that cervical cancer patients with high levels of PKM2 had worse overall survival than those with low levels of PKM2 (hazard ratio = 2.59, log-rank p-value = 0.01). The gene discussed is PKM; the disease is cervical carcinoma.